PI 620

Known as: PI-620, PI620 cpd 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrimidinesThiophenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.
The phosphatidylinositide 3-kinase pathway is frequently deregulated in human cancers and inhibitors offer considerable… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Pharmacological properties of the PI3 kinase (PI3K) inhibitors PI-540 and PI-620
AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA LB-149 The PI3K pathway is highly deregulated in cancer and has been the… (More)
Is this relevant?
2008
2008
The novel potent PI3 Kinase inhibitors, PI-540 and PI-620: Activity in vitro and in vivo
AACR Annual Meeting-- Apr 12-16, 2008; San Diego, CA LB-192 Phosphatidylinositol-3-kinases (PI3K) are lipid kinases that… (More)
Is this relevant?